XML 46 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (Unaudited) (USD $)
Series B Convertible Preferred Stock
Series C Convertible Preferred Stock
Common Stock
Additional Paid-In Capital
Retained Earnings / Accumulated Deficit
Total
Beginning Balance at Dec. 31, 2013     $ 49,015 $ (41,439) $ 17,125 $ 24,701
Beginning Balance, Shares at Dec. 31, 2013     49,015,360      
Net assets outstanding at time the reverse merger was completed, Shares 400,000   10,762,881      
Net assets outstanding at time the reverse merger was completed, Amount 400   10,763 (11,163)      
Common stock issued for cash, Shares     51,758,563      
Common stock issued for cash, Amount     51,759 (43,759)    8,000
Issuance of 3,750,000 Private Placement Units, Shares   3,750,000        
Issuance of 3,750,000 Private Placement Units, Amount   3,750    1,871,250    1,875,000
Issuance cost - Private Placement Units        62,000    62,000
Warrant liability - 1,875,000 warrants issued in connection with Private Placement Units        (227,239)    (227,239)
Stock based compensation        3,567,163    3,567,163
Reclassification of derivative liability warrant       22,282   22,282
Conversion of Series B Convertible Preferred Stock to common stock, Shares (341,327)   34,132,700      
Conversion of Series B Convertible Preferred Stock to common stock, Amount (341)   34,132 (33,791)      
Net loss           (4,019,364) (4,019,364)
Ending Balance, Amount at Jun. 30, 2014 $ 59 $ 3,750 $ 145,669 $ 5,041,304 $ (4,002,239) $ 1,188,543
Ending Balance, Shares at Jun. 30, 2014 58,673 3,750,000 145,669,504